Neha Vapiwala, MD
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 4 de noviembre del 2005
Nov 28, 2014 - Figitumumab -- a fully human IgG2 monoclonal antibody -- appears safe for use in sarcoma, with observable anti-tumor activity, according to research published online Dec. 24 in The Lancet Oncology.
Nov 28, 2014
Oct 28, 2010